dc.date.accessioned2020-03-11T20:27:59Z
dc.date.accessioned2022-10-18T22:44:10Z
dc.date.available2020-03-11T20:27:59Z
dc.date.available2022-10-18T22:44:10Z
dc.date.created2020-03-11T20:27:59Z
dc.date.issued2011
dc.identifierhttp://hdl.handle.net/10533/238447
dc.identifier15110031
dc.identifierWOS:000290016800036
dc.identifierno scielo
dc.identifiereid=2-s2.0-79955562266
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4469786
dc.description.abstractInduction of neovascularization by releasing therapeutic growth factors is a promising application of cell-based gene therapy to treat ischemia-related problems. In the present study, we have developed a new strategy based on nucleofection with alternativ
dc.languageeng
dc.relationhttps://doi.org/10.1371/journal.pone.0019192
dc.relation10.1371/journal.pone.0019192
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.titleEnhanced collateral growth by double transplantation of gene-nucleofected fibroblasts in ischemic hindlimb of rats.
dc.typeArticulo


Este ítem pertenece a la siguiente institución